URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Michael Becker

Concepts (231)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Neoplastic Stem Cells
6
2004
40
2.180
Why?
Leukemia, Myeloid, Acute
5
2006
183
1.790
Why?
Hematopoiesis
3
2002
129
0.740
Why?
Hematopoietic Stem Cells
5
2002
200
0.540
Why?
Cell Transformation, Neoplastic
4
2002
138
0.460
Why?
Muscle, Smooth, Vascular
5
1992
378
0.450
Why?
Stem Cells
1
2006
361
0.430
Why?
Leukemia, Myeloid
3
2006
121
0.380
Why?
Gene Expression Regulation, Neoplastic
4
2002
266
0.370
Why?
Neoplasms
1
2006
743
0.350
Why?
alpha Catenin
2
2006
3
0.340
Why?
Thromboxane A2
3
1993
12
0.310
Why?
Leukemia
2
2006
158
0.300
Why?
Transcription Factors
1
2002
698
0.290
Why?
Tumor Suppressor Protein p53
3
2002
140
0.280
Why?
Apoptosis
1
2002
855
0.280
Why?
Receptors, Prostaglandin
2
1992
7
0.270
Why?
Hematopoietic Stem Cell Transplantation
3
2003
133
0.260
Why?
Cell Differentiation
3
2006
1127
0.250
Why?
Gene Expression Regulation, Leukemic
2
2010
19
0.250
Why?
Animals
13
1992
16416
0.240
Why?
Flow Cytometry
3
2006
603
0.240
Why?
Humans
17
1993
37165
0.230
Why?
Mutation
3
2006
1226
0.220
Why?
Receptors, Thrombopoietin
1
2012
9
0.220
Why?
Hydrazines
1
2012
14
0.220
Why?
Bicyclo Compounds, Heterocyclic
1
1992
14
0.210
Why?
Benzoates
1
2012
16
0.210
Why?
Cell Division
4
1992
773
0.210
Why?
Signal Transduction
3
1993
1629
0.210
Why?
Pyrazoles
1
2012
59
0.210
Why?
Nuclear Proteins
2
2003
335
0.210
Why?
Chemokine CCL3
1
2011
19
0.210
Why?
Growth Substances
1
1992
103
0.200
Why?
Genome-Wide Association Study
1
2011
23
0.200
Why?
Antigens, CD34
1
2011
52
0.200
Why?
Gene Expression Profiling
2
2009
304
0.200
Why?
Thrombocytopenia
1
2012
77
0.200
Why?
Methylprednisolone
1
2011
46
0.200
Why?
Gastrointestinal Tract
1
2011
26
0.200
Why?
Models, Biological
3
2003
1029
0.200
Why?
Translational Medical Research
1
2011
38
0.200
Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
132
0.190
Why?
Amifostine
1
2010
28
0.190
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2003
13
0.190
Why?
Lymphoma, Large B-Cell, Diffuse
1
2011
80
0.190
Why?
Down-Regulation
1
1992
246
0.190
Why?
Stem Cell Transplantation
1
2012
115
0.190
Why?
Cytoprotection
1
2010
40
0.190
Why?
Cell Separation
1
2011
230
0.190
Why?
Graft vs Host Disease
1
2011
95
0.190
Why?
Myelopoiesis
1
2010
16
0.190
Why?
Lymphoma, Non-Hodgkin
1
2011
113
0.190
Why?
PTEN Phosphohydrolase
1
2010
16
0.190
Why?
CCAAT-Enhancer-Binding Proteins
1
2010
16
0.190
Why?
Glucocorticoids
1
2011
168
0.180
Why?
Lymphoma
1
2010
163
0.180
Why?
Gene Regulatory Networks
1
2009
7
0.170
Why?
Osteoblasts
1
2011
249
0.170
Why?
Tumor Markers, Biological
1
2011
240
0.170
Why?
Receptors, Thromboxane
3
1992
3
0.170
Why?
Multipotent Stem Cells
1
2008
12
0.160
Why?
Genes, p16
1
2008
9
0.160
Why?
Liver
2
2003
884
0.160
Why?
Osteoclasts
1
2011
334
0.160
Why?
Prognosis
1
2011
1078
0.160
Why?
Genes, p53
1
2008
51
0.160
Why?
DNA Mutational Analysis
1
2008
192
0.160
Why?
Sesquiterpenes
1
2007
26
0.150
Why?
Mice
6
2003
6206
0.150
Why?
Transplantation, Autologous
3
2010
151
0.150
Why?
Myeloid Progenitor Cells
1
2006
4
0.150
Why?
Chromosomes, Human, Pair 5
1
2006
10
0.150
Why?
Disease Models, Animal
1
2011
974
0.150
Why?
Chromosome Deletion
1
2006
66
0.140
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2010
436
0.140
Why?
Neoplasm Transplantation
1
2006
189
0.140
Why?
Repressor Proteins
2
2003
178
0.140
Why?
Multiple Myeloma
1
2006
75
0.140
Why?
Inositol Phosphates
3
1992
38
0.120
Why?
Neoplasm Recurrence, Local
1
2006
295
0.120
Why?
Male
8
1992
20139
0.120
Why?
Cells, Cultured
5
1992
2589
0.120
Why?
Female
7
1999
20222
0.110
Why?
Brain Neoplasms
1
2006
282
0.110
Why?
Leukemia, B-Cell
1
2002
7
0.110
Why?
Oncogene Proteins, Fusion
1
2002
16
0.110
Why?
Zinc Fingers
1
2002
31
0.110
Why?
Thymus Gland
1
2002
144
0.100
Why?
Prostatic Neoplasms
1
2006
540
0.090
Why?
Proto-Oncogene Proteins
1
2003
301
0.090
Why?
Arthroplasty, Replacement, Knee
1
1999
21
0.090
Why?
Breast Neoplasms
1
2006
666
0.090
Why?
Patients
1
1999
48
0.090
Why?
Arthroplasty, Replacement, Hip
1
1999
46
0.090
Why?
Attitude
1
1999
67
0.090
Why?
Middle Aged
5
1999
10013
0.080
Why?
HL-60 Cells
2
2006
50
0.080
Why?
Adult
5
1999
11572
0.080
Why?
DNA-Binding Proteins
1
2002
691
0.070
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2006
543
0.070
Why?
Blotting, Western
2
2006
672
0.070
Why?
Prostaglandin Endoperoxides, Synthetic
2
1992
4
0.070
Why?
Acute Disease
2
2006
591
0.070
Why?
Fibroblast Growth Factors
1
1994
45
0.060
Why?
Mice, Inbred C57BL
2
2008
1700
0.060
Why?
Treatment Outcome
2
2011
2671
0.060
Why?
Myosin-Light-Chain Kinase
1
1993
13
0.060
Why?
Rats
4
1992
4389
0.060
Why?
Phosphorylation
2
1993
839
0.060
Why?
DNA
3
1992
862
0.060
Why?
Fibroblast Growth Factor 2
1
1993
85
0.060
Why?
Vasoconstrictor Agents
1
1992
31
0.060
Why?
Isometric Contraction
1
1992
46
0.060
Why?
Rats, Sprague-Dawley
2
1992
1036
0.060
Why?
Bicyclo Compounds
1
1992
2
0.050
Why?
Thromboxanes
1
1992
7
0.050
Why?
Prostaglandins
1
1992
67
0.050
Why?
Platelet Count
1
2012
52
0.050
Why?
Protein Kinase C
1
1994
259
0.050
Why?
Fatal Outcome
1
2012
109
0.050
Why?
Blood
1
1992
96
0.050
Why?
Fatty Acids, Unsaturated
1
1992
32
0.050
Why?
Real-Time Polymerase Chain Reaction
1
2011
25
0.050
Why?
Immunocompetence
1
2011
30
0.050
Why?
Injections, Intra-Arterial
1
2011
31
0.050
Why?
Muscle Contraction
1
1993
176
0.050
Why?
Aorta
1
1992
198
0.050
Why?
Aged
3
1999
7392
0.050
Why?
Hydrogen-Ion Concentration
1
1993
611
0.050
Why?
Diphosphonates
1
2011
41
0.050
Why?
Imidazoles
1
2011
67
0.050
Why?
Transplantation, Homologous
1
2012
280
0.050
Why?
Immunoenzyme Techniques
1
2011
214
0.050
Why?
Remission Induction
1
2011
165
0.050
Why?
Pancytopenia
1
2010
14
0.050
Why?
Maximum Tolerated Dose
1
2010
18
0.050
Why?
Melphalan
1
2010
28
0.050
Why?
Mucositis
1
2010
14
0.050
Why?
Bone Density Conservation Agents
1
2011
49
0.050
Why?
Peripheral Blood Stem Cell Transplantation
1
2010
21
0.050
Why?
Carmustine
1
2010
37
0.050
Why?
Transplantation Conditioning
1
2010
36
0.050
Why?
Drug Resistance
1
2011
100
0.050
Why?
Cytarabine
1
2010
93
0.050
Why?
Medical Records
1
2011
140
0.050
Why?
Etoposide
1
2010
83
0.050
Why?
Polymerase Chain Reaction
2
1994
597
0.050
Why?
RNA, Messenger
2
2003
1893
0.050
Why?
Frameshift Mutation
1
2010
22
0.050
Why?
Zebrafish
1
2010
33
0.050
Why?
Bone Marrow
1
2011
292
0.050
Why?
Spleen
1
2011
343
0.050
Why?
Transcription, Genetic
2
1994
824
0.050
Why?
Enzyme-Linked Immunosorbent Assay
1
2011
472
0.050
Why?
Protein Isoforms
1
2010
115
0.040
Why?
Survival Rate
1
2011
619
0.040
Why?
Bone Resorption
1
2011
245
0.040
Why?
Survival Analysis
1
2011
589
0.040
Why?
Atrial Fibrillation
1
2010
112
0.040
Why?
Databases, Nucleic Acid
1
2009
4
0.040
Why?
Combined Modality Therapy
1
2010
491
0.040
Why?
Protein Processing, Post-Translational
1
2010
141
0.040
Why?
Biological Availability
1
2007
38
0.040
Why?
Exons
1
2008
170
0.040
Why?
Drug Design
1
2007
45
0.040
Why?
Cell Proliferation
1
2011
520
0.040
Why?
Cell Count
1
2008
287
0.040
Why?
Dose-Response Relationship, Drug
1
2010
1142
0.040
Why?
U937 Cells
1
2006
18
0.040
Why?
K562 Cells
1
2006
23
0.040
Why?
Hydroxamic Acids
1
2006
20
0.040
Why?
Dogs
1
2007
492
0.040
Why?
Severity of Illness Index
1
2011
943
0.040
Why?
DNA Methylation
1
2006
35
0.040
Why?
Promoter Regions, Genetic
1
2010
558
0.040
Why?
Structure-Activity Relationship
1
2007
316
0.040
Why?
In Situ Hybridization, Fluorescence
1
2006
114
0.040
Why?
Mice, Knockout
1
2010
922
0.040
Why?
Antineoplastic Agents
1
2011
628
0.030
Why?
Green Fluorescent Proteins
1
2006
220
0.030
Why?
Postoperative Complications
1
2010
764
0.030
Why?
Young Adult
1
2010
1084
0.030
Why?
Infant
1
2011
2320
0.030
Why?
Myelodysplastic Syndromes
1
2006
132
0.030
Why?
Tumor Cells, Cultured
1
2007
886
0.030
Why?
Sensitivity and Specificity
1
2008
914
0.030
Why?
Reproducibility of Results
1
2008
903
0.030
Why?
Retrospective Studies
1
2011
2302
0.030
Why?
Cell Line, Tumor
1
2006
576
0.030
Why?
Oxidative Stress
1
2007
347
0.030
Why?
Tumor Suppressor Protein p14ARF
1
2003
5
0.030
Why?
Gene Expression Regulation
2
1994
895
0.030
Why?
Hypertrophy
2
1992
71
0.030
Why?
NF-kappa B
1
2007
434
0.030
Why?
Transfection
1
2006
887
0.030
Why?
Gene Deletion
1
2003
204
0.030
Why?
Child
1
2011
4342
0.030
Why?
Bone Marrow Cells
1
2003
222
0.030
Why?
Cell Line
1
2006
1623
0.030
Why?
Bone Marrow Transplantation
1
2003
201
0.030
Why?
Group Practice
1
1999
13
0.020
Why?
Hospitals, General
1
1999
17
0.020
Why?
Orthopedics
1
1999
39
0.020
Why?
Sex Factors
1
1999
613
0.020
Why?
Age Factors
1
1999
1152
0.020
Why?
Phorbol Esters
1
1994
18
0.020
Why?
Prospective Studies
1
1999
1696
0.020
Why?
Questionnaires
1
1999
1061
0.020
Why?
Immunoblotting
1
1994
225
0.020
Why?
Quinones
1
1993
13
0.010
Why?
Lactams, Macrocyclic
1
1993
16
0.010
Why?
Benzoquinones
1
1993
18
0.010
Why?
Angiotensin II
1
1994
139
0.010
Why?
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
1
1992
5
0.010
Why?
Dinoprost
1
1992
32
0.010
Why?
Thymidine
1
1992
89
0.010
Why?
Leucine
1
1992
108
0.010
Why?
Tyrosine
1
1993
145
0.010
Why?
Protein Kinase Inhibitors
1
1993
97
0.010
Why?
Binding, Competitive
1
1992
210
0.010
Why?
Aged, 80 and over
1
1999
2588
0.010
Why?
Cytosol
1
1992
196
0.010
Why?
Up-Regulation
1
1993
375
0.010
Why?
Dinoprostone
1
1992
205
0.010
Why?
United States
1
1999
2847
0.010
Why?
Protein Biosynthesis
1
1992
257
0.010
Why?
Kinetics
1
1992
1471
0.010
Why?
Base Sequence
1
1993
1721
0.010
Why?
Molecular Sequence Data
1
1993
2046
0.010
Why?
Calcium
1
1992
1135
0.010
Why?

Visualizations


Becker's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department